Fact CheckerSign in

NCT05206695Completed

Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children

The SIP Study: Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children

Source: ClinicalTrials.gov · Last updated 20 Apr 2026

Brief summary (registry, in English)

This study's objective is to identify and test pragmatic and sustainable strategies for implementing a multi-condition clinical pathway intervention for children hospitalized with asthma, pneumonia, or bronchiolitis in community hospitals. The hypothesis is that the multi-condition pathway intervention will be associated with significantly greater increases in clinicians' adoption of evidence-based practices compared to control. The study is a pragmatic, cluster-randomized trial in US community hospitals. The primary outcome will be adoption of evidence-based practices over a sustained period of 2 years. Secondary outcomes include length of hospital stay, intensive care unit transfer, and hospital readmission/emergency department revisit.

Status (registry)
Completed
Study type
Interventional
Enrollment
11760 (actual)
First submitted
11 Jan 2022
Start date
13 May 2022
Primary completion date
21 Oct 2025
Lead sponsor
University of California, San Francisco
Diseases
Asthma
NCT number
NCT05206695

What you commit to

  • Study type: Interventional
  • Participants enrolled: 11760
  • From 13 May 2022 to the primary completion date, 21 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Pre-existing chronic illnesses (e.g., lung disease, cardiovascular disease, neurologic disorders)

Other

  • Diagnosis of SARS-CoV-2
  • Transfer in from another inpatient facility

Who the study is looking for

  • Primary diagnosis of asthma AND age \>2 to \<18 years-old at time of admission to the hospital OR
  • Primary diagnosis of pneumonia AND age \>2 months and \<18 years at time of admission to the hospital OR
  • Primary diagnosis of bronchiolitis AND age \<2 years at time of admission to the hospital

Age in the registry: - to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of California San Francisco
Coordinator of this site? Confirm its status
San FranciscoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.